Results

Total Results: 1,010 records

Showing results for "costs".

221. Screening for HIV: Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/KWfaboZAt9KKoDMQbLvbbt
     June 20, 2019 - (in terms of acceptable cost per quality-adjusted life-year) compared with no screening (24, 25). … One study (25) found that screening populations with even lower prevalence rates is also cost-effective … Neither study, however, reported on the incremental cost-effectiveness of screening lower-risk versus … Expanded screening for HIV in the United States—an analysis of cost-effectiveness. … Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.

222. Patient Questionnaire (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/YbRBU___FZQZ32wgbLdrEU
     October 20, 2008 - important): Overall Sound Quality Reliability Style/Appearance Cost

223. Archived: Thyroid Disease: Screening, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/thyroid-disease-screening-1996
     January 01, 1996 - , regarded as the reference method for FT 4 , is not suitable for routine screening due to its high cost … benefits of treating hyperthyroidism detected by screening are particularly important because of the costs … Case-finding for unsuspected thyroid disease: costs and health benefits. … Sensitivity, specificity, and cost-effectiveness of the sensitive thyrotropin assay in the diagnosis

224. Archived: Alcohol Misuse: Screening and Behavioral Counseling Interventions in Primary Care | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/alcohol-misuse-screening-and-behavioral-counseling-interventions-in-primary-care-2013
     May 15, 2013 - The USPSTF does not consider the costs of providing a service in this assessment. … Costs Behavioral counseling interventions are associated with a time commitment ranging from 5 minutes … There are potential financial costs for parents and caregivers from lost work hours and travel to and

225. Draft Research Plan: Asymptomatic Carotid Artery Stenosis: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/asymptomatic-carotid-artery-stenosis-screening
     August 15, 2019 - controlled trials KQ 4: Randomized, controlled trials; large cohort studies or registries All KQs: Cost-effectiveness

226. Archived: Vitamin Supplementation to Prevent Cancer and CVD: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/vitamin-supplementation-to-prevent-cancer-and-cvd-counseling-february-2014
     February 15, 2014 - The USPSTF does not consider the costs of providing a service in this assessment. … Costs Although dietary supplements themselves are not particularly costly, the cumulative effect of

227. Final Research Plan: Genital Herpes Infection: Serologic Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/genital-herpes-serologic-screening
     December 02, 2021 - antiviral medications); psychosocial harms related to counseling or behavioral interventions All KQs: Cost-effectiveness … or cost-related outcomes, transmission of other sexually transmitted infections (e.g., HIV) KQ 3:

228. Archived: Elevated Lead Levels in Childhood and Pregnancy: Screening, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/elevated-lead-levels-childhood-pregnancy-screening-1996
     January 01, 1996 - lead screening will have a low yield, and many unaffected children will be tested at potentially high cost … prevalence of elevated blood lead levels, universal screening may result in disproportionate risks and costs … for effectiveness of early detection, such as available resources, competing public health needs, and costs … The results of cost-benefit analyses, available resources and public health priorities are among the … on the grounds of limited and conflicting evidence regarding the current burden of suffering, high costs

229. Archived: Rh(D) Incompatibility: Screening, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/rhd-incompatibility-screening-1996
     January 01, 1996 - prophylaxis on the incidence of D disease is relatively small, making it approximately 16 times less cost-effective … than a program consisting only of postpartum treatment. 2 , 59 , 60 Other studies support the cost-effectiveness … of antepartum prophylaxis. 21 , 61 The cost-effectiveness of D immunoglobulin after obstetric procedures … Prevention of Rh(D) alloimmunization: a cost-benefit analysis. … Cost-effectiveness of antepartum prevention of Rh immunization.

230. Archived: Folic Acid/Folate Prophylaxis to Prevent Neural Tube Defects: Preventive Medication, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/folic-acid-prevent-neural-tube-defects-preventive-medication-1996
     January 01, 1996 - Based on 1988 cross-sectional data, the estimated lifetime cost of spina bifida is $258,000 per case. … The effort required to assess dietary folate intake adequately may outweigh the costs and potential harms … not wish to take folic acid supplements may be recommended on other grounds, including low risk, low cost … Estimates of the economic costs of birth defects. Inquiry . 1994;31:188–205. [ PubMed ] 3. … Maternal serum alpha-fetoprotein screening: benefits, risks, and costs.

231. Archived: Final Evidence Review: Hepatitis B in Pregnant Women: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review48/hepatitis-b-in-pregnant-women-screening
     June 15, 2009 - pregnant women include false-positive test results, which may lead to psychological harms, increased costs

232. Archived: Final Evidence Review: Hepatitis B in Pregnant Women: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review48/hepatitis-b-in-pregnant-women-screening-2009
     June 15, 2009 - pregnant women include false-positive test results, which may lead to psychological harms, increased costs

233. Screening for Hepatitis B Virus Infection in Pregnant Women: Evidence for the Reaffirmation Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/mEtSwJk3YPA4BXJ8eZyD2S
     June 01, 2009 - pregnant women include false-positive test results, which may lead to psychological harms, increased costs

234. Final Research Plan: Vision in Children Ages 6 Months to 5 Years: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/vision-in-children-ages-6-months-to-5-years-screening
     December 17, 2015 - psychological effects, false-positive results, and adverse effects on vision in the nonimpaired eye Cost-effectiveness … or cost-related outcomes KQ 2: Studies only providing associations, correlations, or other outcomes

235. Archived: Genital Herpes: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/genital-herpes-screening-2005
     March 15, 2005 - 11-13 There is limited evidence on the safety of antiviral treatments during pregnancy. 25 , 26 A cost … analysis of oral acyclovir prophylaxis in late pregnancy was compared with the current standard of cesarean … that screening at-risk pregnant women and suppressive therapy in their seropositive partners were more cost-effective … interventions (at a cost of $363,000 per case of neonatal infection prevented) compared with no management … Acyclovir prophylaxis in late pregnancy to prevent neonatal herpes: a cost-effectiveness analysis.

236. Archived: Syphilis Infection in Nonpregnant Adults and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/syphilis-infection-in-nonpregnant-adults-and-adolescents-june-2016
     June 07, 2016 - The USPSTF does not consider the costs of providing a service in this assessment. … Potential harms of screening include opportunity costs to the clinician and patient (eg, time and resources

237. Carol M. Mangione, M.D., M.S.P.H. | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/current-members/carol-m-mangione-md-msph
     March 01, 2022 - of Coordinated Medical, Behavioral, and Social Services to Improve Care and Utilization among High-Cost

238. Recommendation: Ovarian Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/ovarian-cancer-screening
     February 13, 2018 - The USPSTF does not consider the costs of providing a service in this assessment. … The USPSTF issued its recommendation against screening based on this evidence, not on the costs of screening

239. Screening for Celiac Disease: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/_ufHxz9_tYMm3Z3r7U7SNj
     March 28, 2017 - of both the benefits andharmsoftheserviceandanassessmentofthebalance.TheUSPSTF does not consider the costs … do not undergo histologic confirmation may make efforts to avoid dietary gluten, which can increase costs

240. Ztmgupsekcuuupvpegum45 (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZTMgupsEkCUuuPVpeGUm45
     September 01, 2013 - The USPSTF does not consider the costs of providing a service in this assessment. … Others addressed the costs of screening in the birth cohort and how HCV treatment may be inaccessible … The USPSTF does not make recommendations on insurance coverage or assess or consider financial costs. … The cost-effectiveness of birth-cohort screening for hepatitis C anti- body in U.S. primary care settings … Cost-effectiveness analysis of risk-factor guided and birth-cohort screening for chronic hepatitis C